Biomedical Research Goes Viral: Dangers and Opportunities.

Clicks: 293
ID: 106824
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #35 of 72 articles by views in Cell

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Researchers around the globe have been mounting, accelerating, and redeploying efforts across disciplines and organizations to tackle the SARS-CoV-2 outbreak. However, humankind continues to be afflicted by numerous other devastating diseases in increasing numbers. Here, we outline considerations and opportunities toward striking a good balance between maintaining and redefining research priorities.
Reference Key
zeggini2020biomedicalcell Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Zeggini, Eleftheria;Baumann, Michael;Götz, Magdalena;Herzig, Stephan;Hrabe de Angelis, Martin;Tschöp, Matthias H;
Journal Cell
Year 2020
DOI
S0092-8674(20)30576-6
URL
Keywords
Cancer proteasome neurodegeneration sars-cov-2 proteasome inhibitors

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.